Search Results - M. Coiras

Virological impact of HCV elimination with DAAs in the HIV reservoir in HIV/HCV patients by M. Coiras, P. Martínez-Román, C. Crespo-Bermejo, A. Fernández-Rodríguez, V. Briz

Connect to this object online.

Peripheral blood lymphocytes from patients with chronic myeloid leukemia on treatment with dasatinib are resistant to HIV-1 infection by M. Coiras, M. Bermejo, J. García-Pérez, J. Ambrosioni, J.M. Miró, M. Plana, J. Alcamí

Connect to this object online.

Tyrosine kinase inhibition: the new front in HIV cure efforts by V. Planelles, M. Szaniawski, E. Williams, E. Innis, L. Martins, A. Spivak, J. Alcami, M. Coiras

Connect to this object online.

OP 5.3 - 00082 1-year treatment with ponatinib provides protection of CD4+T cells against HIV that is maintained at least 1 year more after treatment interruption by M. Manzanares, F. Ramos-Martín, G. Casado-Fernández, M. Torres, E. Mateos, L. Vigón, S. Rodríguez-Mora, V. García-Gutiérrez, V. Planelles, M. Coiras

Connect to this object online.

OP 5.5 - 00083 Impairment of HIV proviral reactivation by interfering with essential metabolic pathways in effector memory CD4+ T cells by G. Casado Fernández, M. Martínez Velasco, S. Rodríguez-Mora, M. Torres, M. Cervero, C. Hoffmann, C. Wyen, E. San José, V. Planelles, M. Coiras

Connect to this object online.

Effect of tyrosine kinase inhibitors on the cytotoxic activity against HIV-1 infection by S. Rodríguez-Mora, G. Bautista, E. Mateos, V. García, J.L. Steegmann, J. Ambrosioni, Nuria Climent, F. Cervantes, J.M. Miró, M. Plana, J. Alcamí, M. Coiras

Connect to this object online.

Differences in the proviral HIV DNA between HIV monoinfected and HIV/HCV coinfected individuals by M.S. Carrillo, B.E. Cartelle, M.G. Arquero, L.M. Carbonero, L. Domínguez-Domínguez, P. Ryan, I. Santos, de los, S. Fuente, de la, O. Bisbal, M. Matarranz, M. Lagarde, A. Moreno, J.M. Castro, E. Mateos, J. Alcamí, S. Resino, A.F. Rodríguez, M. Coiras, V. Briz

Connect to this object online.